183 results
20-F/A
EX-4.40
c6eagx fi0kl
31 May 16
Annual report (foreign) (amended)
12:00am
6-K
mgli4n7yceui
4 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
wxvn2ebm7
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
k069xwjroeoef6w1c7
16 Jun 22
BioLineRx Announces Appointment of Commercial Strategy
7:05am
20FR12B
EX-4.24
1p9owjq8pthklk6z1k
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
6-K
EX-99.1
nc3x 07kbz
3 Mar 14
Current report (foreign)
12:00am
F-1
EX-10.17
oebn5nn
24 Sep 10
Registration statement (foreign)
12:00am
6-K
EX-99
axomk9
8 Jan 14
Current report (foreign)
12:00am
20FR12B
EX-4.17
x8yemo0o2qs i5
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
UPLOAD
kk5w5rzbsugnp9i91d2t
6 Jan 21
Letter from SEC
12:00am
20-F/A
EX-12.2
8rpeezd
31 May 16
Annual report (foreign) (amended)
12:00am